ArticleFrontiers in oncology2022

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis.

Lupeng Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.